Investor Optimism Abounds Simply Better Brands Corp. (CVE:SBBC) But Growth Is Lacking
Nov 20
Have your own idea? Try our Stock Screener
Canadian (TSX) Pharma Industry Analysis
UpdatedNov 20, 2024
DataAggregated Company Financials
Companies70
- 7D-2.4%
- 3M-27.1%
- 1Y-22.8%
- YTD-20.2%
Over the last 7 days, the Pharma industry has dropped 2.4%, driven by a pullback from Trulieve Cannabis of 13%. In contrast, Cipher Pharmaceuticals has gained 15%. Overall the industry is down 23% in 12 months. As for the next few years, earnings are expected to grow by 53% per annum.
Industry Valuation and Performance
Has the Canadian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | CA$14.7b | CA$12.0b | -CA$2,670,865,146.84 | 16.9x | -5.5x | 1.2x |
| Sat, 19 Oct 2024 | CA$19.0b | CA$11.8b | -CA$2,708,707,823.96 | 17.4x | -7x | 1.6x |
| Mon, 16 Sep 2024 | CA$18.1b | CA$11.6b | -CA$2,703,089,761.51 | 20.7x | -6.7x | 1.6x |
| Wed, 14 Aug 2024 | CA$18.6b | CA$11.7b | -CA$2,767,314,339.17 | 22.5x | -6.7x | 1.6x |
| Fri, 12 Jul 2024 | CA$18.7b | CA$11.7b | -CA$3,179,115,064.66 | 19.7x | -5.9x | 1.6x |
| Sun, 09 Jun 2024 | CA$20.8b | CA$11.8b | -CA$2,756,296,099.68 | 12.8x | -7.5x | 1.8x |
| Tue, 07 May 2024 | CA$24.2b | CA$11.8b | -CA$3,417,258,262.83 | 10.9x | -7.1x | 2x |
| Thu, 04 Apr 2024 | CA$20.9b | CA$10.4b | -CA$3,522,094,811.72 | 9x | -5.9x | 2x |
| Sat, 02 Mar 2024 | CA$21.0b | CA$12.0b | -CA$4,470,416,386.14 | 9.4x | -4.7x | 1.8x |
| Mon, 29 Jan 2024 | CA$22.3b | CA$12.3b | -CA$6,748,442,370.00 | 9.6x | -3.3x | 1.8x |
| Wed, 27 Dec 2023 | CA$17.1b | CA$12.2b | -CA$6,713,748,928.00 | 8.6x | -2.5x | 1.4x |
| Fri, 24 Nov 2023 | CA$18.3b | CA$12.5b | -CA$6,838,777,984.00 | 7.1x | -2.7x | 1.5x |
| Sun, 22 Oct 2023 | CA$17.3b | CA$12.4b | -CA$7,341,920,600.00 | 12x | -2.4x | 1.4x |
| Tue, 19 Sep 2023 | CA$22.3b | CA$13.0b | -CA$7,885,143,211.00 | 14.6x | -2.8x | 1.7x |
| Thu, 17 Aug 2023 | CA$13.7b | CA$13.0b | -CA$8,070,709,387.00 | 10.8x | -1.7x | 1.1x |
| Sat, 15 Jul 2023 | CA$15.9b | CA$13.2b | -CA$9,718,923,315.00 | 12.4x | -1.6x | 1.2x |
| Mon, 12 Jun 2023 | CA$14.8b | CA$13.2b | -CA$10,391,543,924.00 | 10.4x | -1.4x | 1.1x |
| Wed, 10 May 2023 | CA$16.2b | CA$13.2b | -CA$10,182,325,882.00 | 10.2x | -1.6x | 1.2x |
| Fri, 07 Apr 2023 | CA$15.5b | CA$13.4b | -CA$10,028,081,302.00 | 11x | -1.5x | 1.2x |
| Sun, 05 Mar 2023 | CA$20.0b | CA$13.7b | -CA$10,313,144,570.00 | 10x | -1.9x | 1.5x |
| Tue, 31 Jan 2023 | CA$19.2b | CA$13.5b | -CA$10,101,272,930.00 | 14.3x | -1.9x | 1.4x |
| Thu, 29 Dec 2022 | CA$18.8b | CA$13.7b | -CA$10,145,605,747.00 | 14.9x | -1.9x | 1.4x |
| Sat, 26 Nov 2022 | CA$30.1b | CA$13.4b | -CA$10,220,329,851.00 | 10.9x | -2.9x | 2.2x |
| Mon, 24 Oct 2022 | CA$27.8b | CA$13.5b | -CA$9,412,446,867.00 | 11.1x | -3x | 2.1x |
| Wed, 21 Sep 2022 | CA$27.6b | CA$13.2b | -CA$8,854,486,701.00 | 12.1x | -3.1x | 2.1x |
| Fri, 19 Aug 2022 | CA$28.1b | CA$11.8b | -CA$8,462,333,139.00 | 14.5x | -3.3x | 2.4x |
| Sun, 17 Jul 2022 | CA$26.8b | CA$12.3b | -CA$5,883,027,436.00 | 11x | -4.6x | 2.2x |
| Tue, 14 Jun 2022 | CA$28.7b | CA$12.4b | -CA$5,520,980,760.00 | 7.7x | -5.2x | 2.3x |
| Thu, 12 May 2022 | CA$31.4b | CA$11.8b | -CA$4,645,653,506.00 | 11.6x | -6.8x | 2.7x |
| Sat, 09 Apr 2022 | CA$42.1b | CA$11.7b | -CA$4,623,187,205.00 | 13.2x | -9.1x | 3.6x |
| Mon, 07 Mar 2022 | CA$40.8b | CA$10.7b | -CA$4,388,549,955.00 | 15.4x | -9.3x | 3.8x |
| Wed, 02 Feb 2022 | CA$49.0b | CA$10.5b | -CA$5,163,351,475.00 | 15.5x | -9.5x | 4.7x |
| Fri, 31 Dec 2021 | CA$53.4b | CA$10.9b | -CA$4,981,643,558.00 | 13.3x | -10.7x | 4.9x |
| Sun, 28 Nov 2021 | CA$65.8b | CA$10.9b | -CA$4,813,309,445.00 | 20x | -13.7x | 6.1x |
Price to Earnings Ratio
-13.7x
Current Industry PE
- Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 1.2x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 3.3% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Canadian Healthcare industry?
| CA Market | 0.41% | |
| Healthcare | -1.56% | |
| Pharma | -2.36% | |
| Pharma | -2.36% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CPH Cipher Pharmaceuticals | CA$14.72 | 15.8% +CA$51.4m | 139.3% | PE17x | |
| SBBC Simply Better Brands | CA$0.82 | 28.1% +CA$16.9m | 221.6% | PS0.8x | |
| NRX NurExone Biologic | CA$0.76 | 20.6% +CA$9.6m | 157.6% | PB15.6x | |
| GRIN Grown Rogue International | CA$0.97 | 3.2% +CA$6.7m | 158.7% | PE40x | |
| GUD Knight Therapeutics | CA$5.21 | 1.2% +CA$6.0m | -1.7% | PS1.5x |
